Acentra Health welcomes noted public sector health leaders Calder Lynch and Jami Snyder to its healthcare advisory board; appoints Julie Boughn as chair.
SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing. This milestone funding round was co-led by SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. Additional support came from existing investor Morningside, alongsi...
LOS ANGELES , Jan. 29, 2025 /PRNewswire/ -- Entertainment 360, one of the world's premier talent management companies, announced today that it would be receiving an investment from global investment firm Carlyle. The transaction marks the first time in Entertainment 360's 22-year history that the company has received outside funding.
Japan's share of all private equity and venture capital investments in Asia-Pacific grew in 2024 as the value of private equity deals targeting Japanese companies surged. Momentum is expected to continue in 2025, pushing private equity transaction value - and the competition among firms hunting deals - even higher this year, said Hajime Koyanagi, general manager of the investment strategy depar...
MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025.
Carlyle has lined up bankers to explore a sale of its British funds network and data business Calastone, which would be the latest deal in a sector that has attracted billions of pounds from investors, four people familiar with the matter said.
Carlyle Group, led by CEO Harvey Schwartz, is well-positioned for long-term success with robust fundraising, strong leadership, and growing fee-related earnings. The firm has achieved record assets under management at $450 billion and aims for $1.1 billion in fee-related earnings this year. Carlyle offers a 2.77% dividend yield and has a substantial share repurchase program, enhancing sharehold...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.